Aurinia Pharmaceuticals Inc. (AUPH) vs Pharvaris N.V. (PHVS)
A side-by-side comparison of Aurinia Pharmaceuticals Inc. and Pharvaris N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AUPH
Aurinia Pharmaceuticals Inc.
$15.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PHVS
Pharvaris N.V.
$31.12HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AUPH vs PHVS
growth of $100 · dividends reinvested · last 6yAUPH -2.1% (-0.4%/yr)PHVS +5.1% (+0.8%/yr)PHVS compounded faster over this window
AUPH PHVS
AUPH vs PHVS: by the numbers
- •PHVS is the larger company ($2.17B vs $2.02B market cap).
- •AUPH is profitable (100.84% net margin) while PHVS runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | AUPH | PHVS |
|---|---|---|
| P/E ratio | 6.85 | N/A |
| Forward P/E | 16.62 | N/A |
| P/S ratio | 6.48 | N/A |
| P/B ratio | 3.28 | 6.33 |
| EV / EBITDA | 11.16 | N/A |
| FCF yield | 8.60% | N/A |
Profitability
| Metric | AUPH | PHVS |
|---|---|---|
| Gross margin | 90.36% | 0.00% |
| Operating margin | 37.06% | 0.00% |
| Net margin | 100.84% | 0.00% |
| ROE | 51.09% | -57.96% |
| ROIC | 21.77% | -61.74% |
Growth (annualized)
| Metric | AUPH | PHVS |
|---|---|---|
| Revenue CAGR (5Y) | 40.17% | N/A |
| Total return CAGR (5Y) | -5.88% | 11.45% |
Frequently asked
- Is AUPH or PHVS more profitable?
- AUPH runs the higher net margin — AUPH at 100.84% versus PHVS at 0.00%.
- How have AUPH and PHVS total returns compared?
- Over the past 5 years, AUPH delivered -5.88% and PHVS delivered 11.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Aurinia Pharmaceuticals P/E ratioAurinia Pharmaceuticals ROEPharvaris ROEAurinia Pharmaceuticals operating marginPharvaris operating marginAurinia Pharmaceuticals revenue growthPharvaris revenue growthAurinia Pharmaceuticals free cash flowPharvaris free cash flow
Aurinia Pharmaceuticals & Pharvaris appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.